Walgreens Boots Alliance, Inc. $WBA Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 33.4% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 136,528 shares of the pharmacy operator’s stock after selling 68,451 shares during the period. Wellington Management Group LLP’s holdings in Walgreens Boots Alliance were worth $1,525,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in WBA. Marshall Wace LLP acquired a new position in Walgreens Boots Alliance during the fourth quarter worth $198,000. First Trust Advisors LP acquired a new position in Walgreens Boots Alliance during the fourth quarter worth $368,000. Dimensional Fund Advisors LP grew its holdings in shares of Walgreens Boots Alliance by 17.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,823,924 shares of the pharmacy operator’s stock worth $17,016,000 after buying an additional 272,895 shares in the last quarter. Northern Trust Corp grew its holdings in shares of Walgreens Boots Alliance by 18.8% during the fourth quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator’s stock worth $83,007,000 after buying an additional 1,407,973 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV grew its holdings in shares of Walgreens Boots Alliance by 67.8% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 112,248 shares of the pharmacy operator’s stock worth $1,021,000 after buying an additional 45,367 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $11.98 on Monday. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $13.25. The firm has a 50-day moving average price of $11.69 and a 200 day moving average price of $11.27. The firm has a market capitalization of $10.37 billion, a P/E ratio of -1.64, a P/E/G ratio of 1.42 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The firm had revenue of $38.99 billion during the quarter, compared to analyst estimates of $36.72 billion. During the same quarter in the prior year, the firm posted $0.63 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 7.2% on a year-over-year basis. Sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. UBS Group reaffirmed a “neutral” rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Morgan Stanley reaffirmed an “underweight” rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Finally, Wall Street Zen assumed coverage on shares of Walgreens Boots Alliance in a report on Wednesday, May 21st. They set a “hold” rating for the company. One analyst has rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus target price of $10.15.

View Our Latest Stock Analysis on WBA

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.